A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.

The U.S. Food and Drug Administration approved Eli Lilly’s drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing.

  • @Senshi
    link
    1211 months ago

    That’s like telling depressed people “just don’t be so down”. It shows a lack of empathy as well as medical ignorance.